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Aim: Present study aims to study the occurrence of cirrhotic cardiomyopathy and its cor-
relation to hepatorenal syndrome by assessing the cardiac status in patients with cirrhosis
of liver and healthy controls.
Methods: Thirty alcoholic cirrhotic, thirty non-alcoholic cirrhotic and thirty controls were
enrolled for the study. Cardiac parameters were assessed by color doppler echocardiography.
Patientswere followedupfor twelvemonthsperiod fordevelopmentofhepatorenal syndrome.
Results: Mild diastolic dysfunction was present in 18 cirrhotic patients (30%): grade I in
fifteen patients and grade II in three. Diastolic dysfunction was unrelated to age; sex and
etiology of cirrhosis. Among all the echocardiographic parameters, only deceleration time
was found to be statistically significant. Echocardiographic parameters in systolic and
diastolic function were not different in compensated vs decompensated patients in
different Child-Pugh classes or cirrhosis aetiologies.
At one year follow-up, no significant differences were found in survival between pa-
tients with or without diastolic dysfunction. Hepatorenal syndrome developed in only two
patients and its correlation with diastolic dysfunction was not statistically significant.
Conclusions: Present study shows that although diastolic dysfunction is a frequent event in
cirrhosis, it is usually of mild degree and does not correlate with severity of liver
dysfunction. There are no significant differences in echocardiographic parameters between
alcoholic and non-alcoholic cirrhosis. HRS is not correlated to diastolic dysfunction in
cirrhotic patients. There is no difference in survival at one year between patients with or
without diastolic dysfunction. Diastolic dysfunction in cirrhosis is unrelated to circulatory
dysfunction, ascites and HRS.
Copyright © 2014, Cardiological Society of India. All rights reserved.8; fax: þ91 2223021168.
.co.in (P.O. Somani).
ociety of India. All rights reserved.
i n d i a n h e a r t j o u r n a l 6 6 ( 2 0 1 4 ) 6 4 9e6 5 56501. IntroductionThe cardiovascular complications of cirrhosis have not
received the attention they deserve. More than 50 years ago,
increased cardiac output in alcohol-related cirrhosis was
attributed to either impaired thiamine utilization or the
presence of an endogenous vasodilator.1 Later, it became clear
that cirrhotic cardiac dysfunction is predominantly governed
by peripheral vasodilatation. There is now substantial evi-
dence that a hyperdynamic syndrome is due to impaired liver
function and portal hypertension with splanchnic vasodila-
tation.2 Subsequent studies described an impaired hemody-
namic response to physiologic (exercise) and pharmacologic
stress despite a high resting cardiac output. For a long time,
these changes were thought to be the effect of alcohol and not
cirrhosis. Animal models of alcoholic cirrhosis confirmed
these findings. They were found to be related to decreased
myocardial contractile function and were corroborated by
additional human studies.3
Experimental and clinical studies have shown impaired
myocardial contractility and electrophysiological abnormal-
ities in cirrhosis, leading to a clinical entity called ‘‘cirrhotic
cardiomyopathy”.4,5 This term denotes a chronic cardiac
dysfunction. Blunted contractile responsiveness to stress and
altered diastolic relaxation with electrophysiological abnor-
malities, such as prolongation of the QT interval occur in
the absence of any other cardiac disease.6,7 This may affect
the prognosis of the patients and aggravate the course
during invasive procedures such as surgery, insertion of
transjugular intrahepatic portosystemic shunts, and liver
transplantation.8,9
Cardiac failure has emerged as an important cause of
mortality after liver transplantation and accounts for 7e21%
of deaths in post orthotopic liver transplantation period.10
Diastolic dysfunction has been proved to be an early marker
of cardiac dysfunction occurring before systolic dysfunction at
rest.11 Also, there are some studies showing correlation be-
tween cirrhotic cardiomyopathy and development of hep-
atorenal syndrome (HRS).12,13
Left ventricular diastolic dysfunction is the cardiac ab-
normality most frequently investigated in cirrhosis. It is pre-
sent in 30e50% of patients.14 Diastolic function in majority of
studies has been assessed by measuring mitral inflow by
Doppler echocardiography, with few studies using the more
modern Tissue Doppler Imaging (TDI) technique.14,15
There is paucity of data from South-east Asia and the In-
dian subcontinent on cirrhotic cardiomyopathy. Apart from a
study on cardiac dysfunction in cirrhotic and non-cirrhotic
portal hypertension16 and another study from Mumbai17
there is hardly any information on the status of cardiac ab-
normalities in Asian patients with cirrhosis.
We undertook this study with the primary objective to
study cardiac status in patients with cirrhosis of liver in
comparison to healthy controls to assess the occurrence of
cirrhotic cardiomyopathy and its correlation to HRS. The
secondary objective was to assess the correlation of echocar-
diographic parameters of cardiac dysfunction with the
severity of liver dysfunction, and to assess whether or not
there are significant differences in these parameters betweenpatients with alcoholic and non-alcoholic cirrhosis. The
prevalence of diastolic dysfunction and its relation to liver
failure and prognosis were also investigated.2. Patients and methods
Cirrhotic patients, either admitted in hospital or followed as
out-patients, were considered for the study. Diagnosis of
cirrhosis was established through histology and/or a combi-
nation of clinical, biochemical and imaging findings.
Patients were excluded from the study if they had evidence
of cardiovascular disease, respiratory disease, renal disease or
any other major systemic disease. Other exclusion criteria
were: (1) cardiac arrhythmias or pulse rate > 100/min; (2)
recent bleeding (<3 months); (3) Hemoglobin < 9 gm/dl; (4)
serum creatinine > 1.5 mg/dl; (5) patients with hypertension,
diabetes; (6) patients receiving drugs like spironolactone, beta
blockers, nitrates, anti-hypertensive agents, and sympatho-
mimetics at present or anytime in the past; (7) patients
suffering from cirrhosis of mixed etiology (to observe any
difference of diastolic dysfunction between alcoholic and
non-alcoholic group and to avoid possible confounding factor)
and (8) Age <18 and >75 years.
Finally, we included sixty cirrhotics. A third group, age and
sex matched thirty healthy subjects on normal diet, served as
controls.
Approval of the study protocol was obtained from the
institutional ethical committee. Informed consent was ob-
tained from all participants. Patients were followed up for a
year.
2.1. Clinical and biochemical evaluation
Detailed clinical history was recorded. Patients underwent
clinical examination and blood investigations. Liver function
was quantified by Child-Pugh and MELD scores.
2.2. Echocardiography
Echocardiography was performed by an experienced operator
in accordance with the recommendations of the American
Society of Echocardiography.18 From a long axis parasternal
view, the left ventricular (LV) systolic and diastolic septal wall
thickness (SWST and SWDT), posterior wall thickness (PWTs
and PWTd) and the LV diameter (LVESD and LVEDD) were
measured in M-mode. The LV mass and LV geometry were
calculated accordingly. LV volumes and LV Ejection Fraction
(LVEF) were estimated using Simpson's modified biplane
method. An LVEF above 50% was considered normal. Pulsed
Doppler examination of the LV inflowwas performedwith the
sample volume placed between the mitral leaflet tips. The
following parameters were recorded and measured: peak
early (E wave) and atrial (A wave) flow velocities, their ratio E/
A, and the E wave deceleration time. TDI was obtained from
the four chamber apical view and tissue velocity was calcu-
lated. Themyocardial peak systolic velocity (S0) wasmeasured
in lateral mitral annulus to define systolic function. Tissue
velocities were also measured in the lateral mitral annulus
i n d i a n h e a r t j o u rn a l 6 6 ( 2 0 1 4 ) 6 4 9e6 5 5 651during the diastole to obtain peak myocardial velocities dur-
ing early (E0) and atrial filling (A0) phases. Isovolumetric Ven-
tricular Relaxation Time (IVRT) was measured by TDI. To
evaluate ventricular filling pressure, E/E0 ratio was calculated.
The intra observer variation for echocardiographic measure-
mentswas<10%. Systolic and diastolic functionswere defined
according to American Society of Echocardiography 2009.18
Diastolic dysfunction was divided in three grades of
increasing severity. Mild diastolic dysfunction (grade I) was
defined as mitral E/A ratio < 0.8, dec Time > 200 ms,
IVRT  100 ms, annular E0 < 8 cm/s and E/E0 lateral ratio < 8;
moderate diastolic dysfunction (grade II) as mitral E/A ratio
between 0.8 and 1.5, E/E0 lateral 9 to 12 and E0 < 8 cm/s and
severe diastolic dysfunction (grade III) as E/A  2, dec
Time < 160 ms, IVRT  60 ms, E/E0 lateral > 12. All parameters
were recorded in three cardiac cycles and the mean of the
measurements were taken for analysis. Two independent
cardiologists who were blinded about the patients analyzed
echocardiography recordings. All the patients were followed
up for twelve months period for the development of HRS and
its correlation with cirrhotic cardiomyopathy. The diagnostic
criteria for HRS were those proposed by the International
Ascites Club.19Table 1 e Demographics, liver and renal function tests of
alcoholic and non-alcoholic cirrhotic patients.
Alcoholic Non-alcoholic p-Value
Age (years) 50.7 ± 7.8 48.9 ± 9.8 0.435
Sex (Male:Female) 30:0 18:12 e
BMI (kg/m2) 21.3 ± 2.7 21.7 ± 1.8 0.458
Variablesa
RBS (mg/dl) 85.7 ± 4.6 83.1 ± 6.5 0.6432.3. Statistical analysis
Student-t test was used to compare continuous variables
when the assumption of normality was satisfied, if not, non-
parametric tests were performed. Categorical variables were
analyzed using the Chi-square test or Fisher test as appro-
priate. Survival probability was estimated using the
KaplaneMeier method and survival curves were compared
between 2 or more groups by means of the log-rank test. A
stepwise Cox regression model was fitted to estimate factors
associated with survival. Multivariate comparison was per-
formed without including related variables (for example,
bilirubin, serum creatinine and INRwere not included because
they are contained within the MELD score that had been used
into the analysis). Pearson Correlation was used as a measure
of association between severity of hepatic dysfunction and
cardiac changes. All results are summarized as
mean ± standard deviation unless otherwise specified. All
reported p-values are two-tailed and values of less than 0.05
were considered statistically significant. All statistical anal-
ysis was performed using the SPSS 14.0 program for Windows
(SPSS, Chicago, IL).Bilirubin (mg/dl) 2.5 ± 1.6 1.9 ± 1.3 0.164
SGOT (IU/l) 76.3 ± 47.3 71.1 ± 24.5 0.906
SGPT (IU/l) 38.3 ± 17.6 39.6 ± 20.9 0.282
ALP (IU/l) 193.3 ± 81.2 197.5 ± 97.5 0.779
INR 1.8 ± 0.4 1.7 ± 0.4 0.843
MELD score 15.2 ± 4.4 14.3 ± 4.4 0.378
Urea (mg/dl) 11.3 ± 2.7 11.4 ± 3.7 0.544
Creatinine (mg/dl) 0.9 ± 0.1 0.9 ± 0.2 0.821
BMI, Body mass index; BSA, Body surface area; RBS, Random blood
sugar; SGOT, Serum glutamic oxaloacetic transaminase; SGPT,
Serum glutamic pyruvate transaminase; ALP, Alkaline phospha-
tase; INR, International normalized ratio; MELD, Model for end-
stage liver disease.
a Variables are expressed as mean ± standard deviation.3. Results
3.1. Patient characteristics
A total of 90 individuals, out of whom 30 were alcoholic
cirrhotic patients, 30 were non-alcoholic cirrhotic patients
and 30 healthy subjects of comparable age were recruited for
the study. It was observed that all the patients with alcoholic
cirrhosis were males. Among the 30 patients with non-alco-
holic cirrhosis, 60% were males; and among the 30 controls,
72% were males. Demographics of patients including liverfunction tests, renal function tests and MELD score are shown
in Table 1.
The non-alcoholic group comprised of chronic hepatitis B
(15 patients), chronic hepatitis C (seven patients) and others
(eight patients). Among cirrhotic patients, 8 were Child A
status, 26 were Child B and rest were Child C status. Themean
MELD score was 15.2 ± 4.4 for alcoholic and 14.3 ± 4.4 for non-
alcoholic patients.
3.2. Echocardiographic characteristics
Left ventricle dimensions and mass did not differ between
patients and controls. Cirrhotic patients have higher cardiac
output but did not reach statistical significance. Patients have
higher ejection fraction as compared to controls (p¼ 0.001). All
patients had a left ventricular ejection fraction >50% (that is
the lower value of the normality).
With regard to diastolic function, deceleration time were
significantly prolonged (p ¼ 0.02) in cirrhotics compared to
controls.Milddiastolic dysfunction, according to theAmerican
Society of Echocardiography Guidelines, was present in 18
cirrhotic patients (30%) at rest: grade I in fifteen patients and
grade II in three. No patient had diastolic dysfunction grade 3.
Among alcoholic cirrhotic, nine had diastolic dysfunction
while nine non-alcoholic cirrhotics had diastolic dysfunction.
Prevalenceof cirrhotic cardiomyopathywas found tobe30%.E/
A ratio was not found to be statistically significant.
Diastolic dysfunctionwas seen in two patientswith Child A
status and eight each in Child B and Child C status.
Echocardiographic parameters of cases and controls are
shown in Table 2.
3.3. Patients with versus without diastolic dysfunction
Diastolic dysfunctionwas unrelated to age; sex and etiology of
cirrhosis. Parameters of the severity of liver disease, such as
Child-Pugh class, MELD score, prothrombin time, albumin or
Table 2 e Echocardiographic parameters in cases and
controls.
Variablesa
(Mean ± standard
deviation)
Cases
(n ¼ 60)
Controls
(n ¼ 30)
p-Value
LV end-diastolic
diameter (mm)
44.6 ± 2.6 45.1 ± 3.6 0.73
LV end-systolic
diameter (mm)
24.1 ± 1.8 25.9 ± 3.2 0.55
Interventricular
septum thickness (mm)
8.8 ± 1.2 7.8 ± 0.9 0.061
LV posterior wall
diameter (mm)
8.9 ± 1.0 8.3 ± 0.8 0.072
LV end-diastolic
Volume (ml)
74.0 ± 4.2 71.9 ± 3.3 0.154
LV end-systolic
Volume (ml)
25.0 ± 2.1 26.3 ± 2.0 0.059
LV ejection fraction (%) 66.1 ± 2.8 63.5 ± 2.2 0.001
Systolic volume (ml) 49.0 ± 4.0 45.7 ± 2.6 0.084
Cardiac output (L/min) 3.9 ± 0.4 3.5 ± 0.3 0.078
Cardiac index (L/min/m2) 2.4 ± 0.3 2.2 ± 0.3 0.183
E (cm/s) 65.4 ± 8.2 68.7 ± 7.6 0.068
A (cm/s) 67.3 ± 6.9 65.6 ± 6.5 0.264
E/A ratio 0.98 ± 0.1 1.06 ± 0.1 0.064
Deceleration time (ms) 194.08 ± 35 179.23 ± 18 0.024
a Variables are expressed as mean ± standard deviation.
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groups (Table 3). The diastolic dysfunction was not associated
with cirrhosis etiology and was not more prevalent in alco-
holic cirrhosis.
When patients were stratified according to the degree of
liver impairment (Child-Pugh class or MELD), echocardiogra-
phy parameters were similar (Table 4). There was no differ-
ence in echocardiographic parameters when Child A status
patients were compared to Child B/C status patients. Systolic
and/or diastolic dysfunction was not influenced by a more
severe liver impairment.d
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The mortality rate was 29% after 1 year follow up. 17 patients
died and 41were alive one year after the study. 2 patientswere
lost to follow up. All patients died of complications of liverTable 3 e Clinical, demographical data and liver function
tests in patients divided according to diastolic dysfuction.
Variablea No diastolic
dysfunction
Diastolic
dysfunction
p-Value
Age (yrs) 50.5 ± 9.9 49.5 ± 8.5 n.s.
Sex (M/F) 33/9 16/2 n.s.
Alcoholic cirrhosis 21 9 n.s
Bilirubin (mg/dl) 2.1 ± 1.3 2.2 ± 1.5 0.878
INR 1.9 ± 0.4 1.8 ± 0.4 0.67
MELD score 15.2 ± 4.6 14.6 ± 4.3 0.633
Urea 12.4 ± 3.4 11.8 ± 3.1 0.152
Creatinine 1.0 ± 0.1 0.9 ± 0.1 0.362
INR, International normalized ratio; MELD, Model for end-stage
liver disease.
a Variables are expressed as mean ± standard deviation. T
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i n d i a n h e a r t j o u rn a l 6 6 ( 2 0 1 4 ) 6 4 9e6 5 5 653disease (variceal bleeding; HRS; hepatocellular carcinoma and
liver failure). HRS developed in only two patients over a follow
period of twelve months, one with diastolic dysfunction and
other without diastolic dysfunction. There was no correlation
between diastolic dysfunction and development of HRS. The
leading cause of death did not differ significantly between
patients with or without diastolic dysfunction.
No significant differences were found in survival between
patients with or without diastolic dysfunction (Fig. 1). In the
univariate analysis serum bilirubin, INR, MELD score, hepatic
encephalopathy and Child-Pugh score were associated with 1-
year survival. Diastolic dysfunction did not correlate with
prognosis. In themultivariate analysis MELD score, hepatic en-
cephalopathy and Child-Pugh score were included. MELD score
was the only factor independently associated with survival.4. Discussion
According to Montreal definition of cirrhotic cardiomyopathy,
systolic dysfunction is characterized by blunted increase in
cardiac output with exercise, volume challenge or pharma-
cological stimuli or resting ejection fraction (EF) <55%.2 In our
study, systolic dysfunction on the basis of decreased EF was
not found. Ejection fraction was increased in both alcoholic
and non-alcoholic group as compared to controls (statistically
significant). Patients with cirrhosis generally tend to have
increased ejection fraction. Increased ejection fraction is due
to hyperdynamic circulation in cirrhosis. Pharmacological or
physical stress may unmask a latent left ventricular
dysfunction in patients with cirrhosis, as evidenced by an
increase in left ventricular end-diastolic volume and a
decrease in left ventricular ejection fraction.20 In our study,
such pharmacological or physical stress testing was not done
and systolic function was evaluated only on the basis of
ejection fraction. This is a limitation of present study as cases
of systolic dysfunction might have been under-represented.
There was evidence of diastolic dysfunction in both the
group of cirrhotic patients, as indicated by statistically sig-
nificant prolongation of deceleration time compared to the
controls. The E/A ratio, the other parameter of diastolic
dysfunction, did not show a statistically significant difference
in our study. Diastolic dysfunction in cirrhosis was first re-
ported in 1997.21 The pathophysiological background of theFig. 1 e KaplaneMeier survival analysis.diastolic dysfunction in cirrhosis is an increased stiffness of
the myocardial wall, most likely because of a combination of
mild myocardial hypertrophy, fibrosis, and subendothelial
edema.22 With Doppler echocardiography, Finucci et al found
impaired left ventricular relaxation, decreased E/A ratio, and
delayed early diastolic transmittal filling in patients with
cirrhosis compared with controls.23 The ratio of early-to-late
diastolic filling (E/A) is the most common parameter used for
the estimation of diastolic function in clinical practice. It is
easy to obtain, but it could also be subjected to errors. There
are several parameters that could potentially affect the mea-
surement of the E/A ratio. Echocardiographic indices are
strongly dependent on preload. In the setting of abnormal left
ventricular relaxation and elevated left atrial pressure, pseu-
donormalization of the mitral inflow may occur, thereby
masking the presence of diastolic dysfunction.9 In a study
from Mumbai, E/A ratio was not statistically significant be-
tween cases and controls.17 The E/A ratio, but not deceleration
time, is subject to the phenomenon of ‘pseudonormalization’
whereby the E/A ratio becomes paradoxically normal despite
diastolic dysfunction.24 This could have lead to the E/A ratio
being normal in some patients with diastolic dysfunction in
our study. However, there have been reports of a decrease in
the E/A ratio in cirrhotics, with observations of a statistically
significant decrease in the E/A ratio in cirrhotics with ascites
compared to cirrhotics without ascites and controls.25 E/A
ratio <1 has been included in diagnostic criteria in montreal
definition.2 However, the phenomenon of pseudonormaliza-
tion raises doubts about the validity of the E/A ratio as a
marker of diastolic dysfunction in patient with cirrhosis.
The criteria adopted for the diagnosis of diastolic
dysfunction in cirrhotic patients need, however, to be inter-
preted with caution. Previous studies have based the diag-
nosis of diastolic dysfunction mainly on 2D-Doppler
echocardiography parameters.9,17 However, it is well known
that the E/A ratio is strongly influenced by loading conditions,
and decompensated cirrhotic patients are frequently suffering
a condition of fluid retention. The use of TDI can overcome
some of this criticism, mainly because this echocardiography
method is less influenced by the changes in cardiac load
conditions.14 The American Society of Echocardiography has
included TDI parameters in the definition of diastolic
dysfunction and these criteria have recently been updated.18
In this study, the prevalence of diastolic dysfunction in
cirrhosis was 30%, in most cases it is of mild severity. There
was no patient with grade 3 diastolic dysfunction, and there
were only 3 cases with grade 2. There was no statistical sig-
nificant difference in the prevalence of diastolic dysfunction
among different grades of Child status. No significant differ-
ences were found in survival between patients with or
without diastolic dysfunction at 1 year follow-up.
There was no statistically significant association between
the severity of hepatic dysfunction and cardiac changes.
Cardiac abnormalities at rest were not different in Child B/C vs
Child A patients or MELD>15 vs <15. There are other studies
showing no correlation between diastolic dysfunction and
severity of liver dysfunction.14,17 However, a recent study
states that cardiac changes parallel the severity of hepatic
dysfunction in cirrhotics.15 In our study, majority of the pa-
tients were of Child B and Child C status. As compared to
i n d i a n h e a r t j o u r n a l 6 6 ( 2 0 1 4 ) 6 4 9e6 5 5654study by Alexander et al17 where majority of patients were
Child A or B, we have proper representation of cirrhotic pa-
tients across all classes. The cardiac changes in our patients
seem to be due to cirrhosis rather than alcohol. There was no
statistically significant difference in any of the cardiac pa-
rameters between patients with alcoholic liver disease and
those with non-alcoholic etiologies.
There are recent reports showing correlation between
cirrhotic cardiomyopathy and development of HRS.12,13 HRS is
a functional renal failure due to intense renal vasoconstriction
that frequently develops in patients with cirrhosis and asci-
tes.19 A recent study has revealed that in patients with
cirrhosis and ascites, those with the lowest cardiac index had
the most impaired renal function and the poorest survival.
Hence, the development of HRS and poor outcomes in these
patients seem to be related to cardiac systolic dysfunction.12
In a study by Luis Ruiz-del-Arbol et al, it was concluded
that HRS is the result of a decrease in cardiac output in the
setting of a severe arterial vasodilation.13 In the present study,
patients were followed up for minimum twelve months to
determine the prevalence of HRS and its correlation to
cirrhotic cardiomyopathy. Only 2 patients developed HRS and
this was not statistically significant related to diastolic
dysfunction. HRS develops in patients with low cardiac output
and systolic dysfunction. In this study, majority of the pa-
tients had either normal or high cardiac output and follow-up
period was also less. Also diastolic dysfunction was present in
30% of cirrhotic patients. There is recent study concluding
that diastolic dysfunction in cirrhosis is unrelated to circula-
tory dysfunction, ascites and HRS.15 Similar conclusion is
concluded by our study although low sample size is limitation.
Limitations of the present study were the small sample
size and the unavailability of brain natriuretic peptide and
pro-brain natriuretic peptide, which are also recognized to be
important in the evaluation of diastolic dysfunction.26 More-
over, our study did not include a stress test (physical activity
or pharmacological stress) which could have better evidenced
a sub clinical cardiac dysfunction.5. Conclusion
Present study demonstrated that Indian patients with
cirrhosis do have diastolic dysfunction. In the absence of
other risk factors for cardiac disease, this dysfunction could be
attributed only to cirrhotic cardiomyopathy. It also shows that
although diastolic dysfunction is a frequent event in cirrhosis,
it is usually ofmild degree and does not correlate with severity
of liver dysfunction. There were no significant differences in
echocardiographic parameters between alcoholic and non-
alcoholic cirrhosis. HRS was not found to be correlated to
diastolic dysfunction in cirrhotic patients. There was no dif-
ference in survival at one year between patients with or
without diastolic dysfunction. Diastolic dysfunction in
cirrhosis is unrelated to HRS.Conflicts of interest
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